SC II Acquisition Corp.
Company Information
Industry Blank Checks
SIC Code 6770
Entity Type other
SEC Category Emerging growth company
State of Incorporation Cayman Islands
Business Address 575 FIFTH AVE, NEW YORK, NY, 10018
Mailing Address 575 FIFTH AVE, NEW YORK, NY, 10018
Phone 6462574214
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 16, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 15, 2026 | View on SEC |
| 424B4 Prospectus for IPO or offering | December 4, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 4, 2025 | View on SEC |
| 8-K Current report of material events | December 4, 2025 | View on SEC |
IPO Filings
S-1 October 16, 2025
- SPAC structure aiming to raise $150 million (up to $172.5 million with over-allotment) to acquire a high-growth private company.
- Founders investing $5 million of their own money, aligning interests with investors and signaling confidence.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.